Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Multicenter, Randomized, Controlled, Clinical Trial to Assess the Safety and Efficacy of Injectable Paromomycin in Patients With Visceral Leishmaniasis

NCT00216346 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT00216346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00216346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Multicenter, Randomized, Controlled, Clinical Trial to Assess the Safety and Efficacy of Injectable Paromomycin in Patients With Visceral Leishmaniasis
Lead sponsor
PATH
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2003
Completion date
November 30, 2004
Enrollment
667
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

visceral leishmaniasis